at-risk patient groups
underlying CAMUD technology
modern computer technology
patient organizations
acute events
Europe amounts
ambulances of clinics
monitoring neuropathologies
continuous monitoring
physicians
Initial target market groups
Multispectral Ultrasound Diagnostics
resulting economic damage
Brain Vitals
brain tissue
final realization
Multispectral Ulstrasound Diagnostic Device
specialist's practices
time thanks
emergency organizations
market acceptance
Feasibility Study
stroke units
clinical validation of SoNovum AGâ€™s UltraEASY
novel diagnostic method
feedback of ultrasound waves
therapeutic time frame
development of final innovation strategies
rescue vehicles
System
health insurance carriers
flexibility
helicopters
order
multiple frequencies
non-invasive diagnosis
beginning
regard
examination
patients
seconds
family
small acquisition costs
MedTech sector
project
Phase
molecular acoustics
risk evaluation
high mobility
mobile version
global markets
harmful incidents
basic equipment
things
year
objectives
wake
Europeans